Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine infusion for donor site pain in free flap surgery
NCT03349034Phase 2Completed
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Sep 2017
- Primary completion
- Sep 2019
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain, sponsored by Icahn School of Medicine at Mount Sinai. Started Sep 2017; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03349034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03349034.